Galantamine
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB00674 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 35 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | psychogenic movement disorders | KG + DL |
| 2 | chronic tic disorder | KG + DL |
| 3 | primary orthostatic tremor | KG + DL |
| 4 | extrapyramidal and movement disease | KG + DL |
| 5 | benign shuddering attacks | KG + DL |
| 6 | tremor-nystagmus-duodenal ulcer syndrome | KG + DL |
| 7 | lingual-facial-buccal dyskinesia | KG + DL |
| 8 | benign paroxysmal tonic upgaze of childhood with ataxia | KG + DL |
| 9 | acute intermittent porphyria | KG + DL |
| 10 | porphyria | KG + DL |
| 11 | miscellaneous movement disorder due to neurodegenerative disease | KG + DL |
| 12 | glaucoma | KG + DL |
| 13 | mitochondrial proton-transporting ATP synthase complex deficiency | KG + DL |
| 14 | drug-induced dyskinesia | KG + DL |
| 15 | mitochondrial complex V (ATP synthase) deficiency, nuclear | KG + DL |
| 16 | frontotemporal dementia | KG + DL |
| 17 | PUM1-associated developmental disability-ataxia-seizure syndrome | KG + DL |
| 18 | GRID2-related autosomal dominant spinocerebellar ataxia | KG + DL |
| 19 | ataxia with dementia | KG + DL |
| 20 | X-linked parkinsonism-spasticity syndrome | KG + DL |
| 21 | opiate dependence | KG + DL |
| 22 | intermittent explosive disorder | KG + DL |
| 23 | kleptomania | KG + DL |
| 24 | primary hereditary glaucoma | KG + DL |
| 25 | erythropoietic uroporphyria associated with myeloid malignancy | KG + DL |
| 26 | open-angle glaucoma | KG + DL |
| 27 | learning disability | KG + DL |
| 28 | Creutzfeldt Jacob disease | KG + DL |
| 29 | myoclonic dystonia | KG + DL |
| 30 | cerebrovascular dementia | KG + DL |
| 31 | hereditary photodermatosis | KG + DL |
| 32 | hereditary late onset Parkinson disease | KG + DL |
| 33 | polymicrogyria, perisylvian, with cerebellar hypoplasia and arthrogryposis | KG + DL |
| 34 | Charcot-Marie-Tooth disease, demyelinating, type 1G | KG + DL |
| 35 | dementia pugilistica | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.